Table 1 Baseline characteristics for demographic, clinical and laboratory parameters
Number of patients (n) | 54 |
|---|---|
Sex (women/men) | 36/18 |
Age (years) | 65 ± 13 |
BSA (m2) | 1.8 ± 0.2 |
Etiological subclasses of pulmonary arterial hypertension | |
Idiopathic PAH | 30 (56) |
Heritable PAH | 3 (5) |
PAH associated with CTD | 17 (31) |
PAH associated with portal hypertension | 2 (4) |
Drug and toxin induced PAH | 2 (4) |
Laboratory parameters | |
NT-proBNP (ng/L) | 1698 [375–3147] |
Hemoglobin (g/L) | 141 ± 19 |
Creatinine (µmol/L) | 94 ± 30 |
Comorbidities | |
Diabetes | 15 (28) |
Hypertension | 24 (44) |
Coronary artery disease | 10 (19) |
Previous stroke | 3 (5) |
Thyroid disease | 14 (26) |
Functional class, NYHA | |
I | 1 (2) |
II | 16 (30) |
III | 33 (61) |
IV | 4 (7) |
Medication | |
O2 | 12 (22) |
Diuretics | 26 (48) |
Calcium antagonists | 12 (22) |
Anticoagulation | 7 (13) |